Uncategorized

Novo CEO sees innovation as a matter of survival amid pipeline setbacks

Novo CEO sees innovation as a matter of survival amid pipeline setbacks

Published

on

Novo Nordisk CEO Maziar Mike Doustdar on a second quarter earnings call argued that failure is par for the course in the drug development business. The Danish pharma is focused on building out its pipeline to move past recent clinical roadblocks.​ ​Read More

Leave a Reply

Your email address will not be published. Required fields are marked *

Trending

Exit mobile version